FDA approves new drug for Alzheimer's Disease

Leqembi is the first drug to be available outside of clinical trials. The drug slows the cognitive decline of Alzheimer's patients. Though the drug will be covered by Medicare, there are concerns over the cost and who will get access to it. Dr. Pradeep Kumar, with Austin Gastroenterology, joins us with more.